School of Medicine


Showing 1-10 of 1,039 Results

  • Fahim Abbasi

    Fahim Abbasi

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.

  • Ranjana Advani

    Ranjana Advani

    Saul A. Rosenberg, MD, Professor of Lymphoma

    Current Research and Scholarly InterestsClinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.

    The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.

  • Patrick Cunningham Ahearn, MD, MAS

    Patrick Cunningham Ahearn, MD, MAS

    Clinical Assistant Professor, Medicine - Nephrology

    BioDr. Ahearn is a board-certified nephrologist. He is also a clinical assistant professor in the Stanford University School of Medicine Division of Nephrology.

    He specializes in providing innovative care to kidney disease and transplant patients. He develops a comprehensive, compassionate care plan personalized to each patient in his care.

    In addition to his clinical practice, Dr. Ahearn has conducted research on barriers to transplantation for patients with extended dialysis exposure, disparities in living kidney donation, and disparities in access to kidney transplant. He also has researched kidney transplant outcomes as they relate to the timing of dialysis initiation plus new pharmaceuticals for the kidney transplant population.

    Dr. Ahearn has made presentations on these and other topics to the American Transplant Congress and Society of General Internal Medicine Meeting. He has published peer-reviewed articles on his research topics in the Clinical Journal of the American Society of Nephrology, JAMA Network Open, American Journal of Kidney Diseases, American Journal of Surgery, and elsewhere. He has published abstracts in the Journal of the American Society of Nephrology.

    Dr. Ahearn has earned honors for his research and scholarship. He has received research funding from the National Institute of Diabetes and Digestive and Kidney Diseases.
    Among his honors, Dr. Ahearn was on the kidney transplant team that earned the Stanford Health Care Integrated Strategic Plan Star Award. The team was recognized for delivering excellence in patient care as well as for identifying opportunities to improve care.

    He is a member of the American Society of Nephrology and American Society of Transplantation.

    He has volunteered his time and expertise as a board member of the Village of Hope, a transitional housing program for homeless men, women, and children in Orange County, California. Dr. Ahearn has served as a volunteer and proctor at the free clinic providing medical services to the uninsured.

  • Aijaz Ahmed, MD

    Aijaz Ahmed, MD

    Professor of Medicine (Gastroenterology and Hepatology)

    BioDr. Ahmed is an internationally recognized hepatologist with expertise in the treatment of acute and chronic liver diseases. He is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. Currently, he serves as the Medical Director of the Adult Liver Transplant Program at Stanford University.

    Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University. During his fellowship, he focused on clinical and research training in General and Transplant Hepatology.

    For patients under his care, Dr. Ahmed remains dedicated to creating a personalized, comprehensive, and above-all a compassionate treatment plan. He outlines the diagnostic and follow-up management pathway in an individualized fashion; he updates his patients and their family/support at each step of the decision-making process; and he focuses on prioritizing the wishes of his patients and their family/support for an optimal outcome and quality of life.

    Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada.

    In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford ford University. He remains deeply interested in mentoring trainees and students al levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.

    Dr. Ahmed’s research interests include 1) multidisciplinary approach to nonalcoholic fatty liver disease (NAFLD), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC), and 4) outcomes research in NAFLD, HCC, viral hepatitis, alcoholic liver disease, and liver transplantation. He heads a busy and productive outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.

    He has published his findings in textbooks, abstracts, case reports, and high- profile medical journals including Gastroenterology, Journal of Hepatology, Hepatology American Journal of Gastroenterology, and other well-renowned peer-reviewed publications.

    Dr. Ahmed and his team has made presentations to his peers at many national and international conferences: the American Association for the Study of Liver Disease, International Liver Congress, European Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, and more. His presentations have addressed leading-edge approaches to the treatment of chronic liver disease, liver cancer, and liver failure. He also has presented his insights into the gastrointestinal impact of COVID-19.

    For his clinical, research, and teaching achievements, Dr. Ahmed has earned extensive recognition. His honors include being named as one of America’s Top Physicians by the Consumers’ Research Council of America.

    He is an active member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases.

  • Neera Ahuja

    Neera Ahuja

    Professor of Medicine (Hospital Medicine)

    Current Research and Scholarly InterestsClinical inpatient trials, Quality improvement, Assessing interventions with operations on throughput. SDOH/Health equity
    Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system

  • Kevin M. Alexander, MD, FACC, FHFSA

    Kevin M. Alexander, MD, FACC, FHFSA

    Assistant Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center

    BioDr. Alexander is an advanced heart failure-trained cardiologist. He is also an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine.

    Dr. Alexander specializes in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.

    Dr. Alexander has expertise in diagnosing and treating transthyretin cardiac amyloidosis, a critical yet underdiagnosed cause of heart failure among African Americans and the elderly. He is conducting extensive research to enhance our understanding of this condition, with grant support from the National Institutes of Health and American Heart Association, among other sources.

  • Ash A. Alizadeh, MD/PhD

    Ash A. Alizadeh, MD/PhD

    Moghadam Family Professor

    Current Research and Scholarly InterestsMy research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

    Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.